Bioventus Inc.BVSNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank83
3Y CAGR+30.1%
5Y CAGR+22.1%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+30.1%/yr
vs -11.0%/yr prior
5Y CAGR
+22.1%/yr
Recent acceleration
Acceleration
+41.1pp
Accelerating
Percentile
P83
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$26.49M-31.7%
2024$38.79M-4.6%
2023$40.68M+238.4%
2022$12.02M+981.0%
2021$1.11M-88.6%
2020$9.75M-54.8%
2019$21.58M+12.6%
2018$19.17M+1.4%
2017$18.90M+18.6%
2016$15.94M-